Parathormone stability in hemodialyzed patients and healthy subjects: comparison on non-centrifuged EDTA and serum samples with second- and third-generation assays.
[en] BACKGROUND: Parathyroid hormone (PTH) stability is important. Many studies have shown divergent results between EDTA and serum, which are mainly linked to differences in protocols or cut-offs used to determine whether or not PTH remained stable. No studies have yet compared PTH stability as measured by second- and third-generation assays on the same samples in hemodialyzed patients and healthy subjects. METHODS: Five pairs of samples (EDTA and gel tubes) were obtained in 10 hemodialyzed patients before a dialysis session and in 10 healthy subjects. One pair was centrifuged and run directly to define the "T0". Two pairs were kept at +4 degrees C and two pairs were kept at +25 degrees C. They were centrifuged after 4 and 18 h. Supernatant was kept at -80 degrees C for 1 week. All samples were measured in a single batch, on Roche Cobas and DiaSorin XL second- and third-generation PTH assays. We used three different approaches to evaluate PTH stability: Wilcoxon test, an Acceptable Change Limit (ACL) according to ISO Guide 5725-6 and a Total Change Limit (TCL) derived from the sum of biological and technical variability according to WHO. RESULTS: PTH decreased in all samples. Stability of PTH was mainly dependent on the way it was evaluated. Percentages of decrease were systematically lower in EDTA vs. serum. Wilcoxon and ACL showed that PTH was no more stable after 4 h at +4 degrees C in EDTA or serum gel tubes. None of the subjects presented a PTH decrease higher than the TCL with EDTA plasma. In serum gel tubes, PTH was unstable only when kept at 25 degrees C for 18 h. CONCLUSIONS: PTH seems more stable in EDTA than in serum gel tubes but only when samples have to stay unprocessed for a long period (18 h) at room temperature (25 degrees C), which can happen when samples are delivered from external care centers. For all the other conditions, using serum gel tubes is recommended since calcium measurement, which is necessary for a good PTH results interpretation, can be achieved on the same tube.
Disciplines :
Urology & nephrology Laboratory medicine & medical technology
Author, co-author :
SCHLECK, Marie-Louise ; Centre Hospitalier Universitaire de Liège - CHU > Frais communs Biologie clinique - Pool assistants
Souberbielle, Jean-Claude
DELANAYE, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Service de néphrologie
Plebani, Mario
Cavalier, Etienne ; Université de Liège - ULiège > Département de pharmacie > Chimie médicale
Language :
English
Title :
Parathormone stability in hemodialyzed patients and healthy subjects: comparison on non-centrifuged EDTA and serum samples with second- and third-generation assays.
Delanaye P, Souberbielle J-C, Lafage-Proust MH, Jean G, Cavalier E. Can we use circulating biomarkers to monitor bone turnover in CKD haemodialysis patients Hypotheses and facts. Nephrol Dial Transplant 2014;29:997-1004.
Hanon EA, Sturgeon CM, Lamb EJ. Sampling and storage conditions influencing the measurement of parathyroid hormone in blood samples: A systematic review. Clin Chem Lab Med 2013;51:1925-41.
Cavalier E, Plebani M, Delanaye P, Souberbielle J-C. Considerations in parathyroid hormone testing. Clin Chem Lab Med 2015;53:1913-
Available at: www. degruyter. com/view/j/cclm. Ahead-of-print/ cclm-2015-0314/cclm-2015-0314. xml. Accessed: 2 Jun 2015.
Oddoze C, Lombard E, Portugal H. Stability study of 81 analytes in human whole blood, in serum and in plasma. Clin Biochem 2012;45:464-9. Available at: http://dx. doi. org/10. 1016/j. clinbiochem. 2012. 01. 012. Accessed: 18 Jan 2012.
Scharnhornst V, Valkenburg J, Vosters C, Vader H. Influence of preanalytical factors on the immulite intact parathyroid hormone assay. Clin Chem 2004;50:974-5.
Glendenning P, Laffer LL, Weber HK, Musk AA, Vasikaran SD. Parathyroid hormone is more stable in EDTA plasma than in serum. Clin Chem 2002;48:766-7.
Jane Ellis M, Livesey JH, Evans MJ. Hormone stability in human whole blood. Clin Biochem 2003;36:109-12.
Evans MJ, Livesey JH, Ellis MJ, Yandle TG. Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clin Biochem 2001;34:107-12.
Zwart SR, Wolf M, Rogers A, Rodgers S, Gillman PL, Hitchcox K, et al. Stability of analytes related to clinical chemistry and bone metabolism in blood specimens after delayed processing. Clin Biochem 2009;42:907-10. Available at: http://dx. doi. org/10. 1016/j. clinbiochem. 2009. 02. 010. Accessed: 26 Feb 2009.
Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 2005;16:2205-15.
Holmes DT, Levin A, Forer B, Rosenberg F. Preanalytical influences on DPC IMMULITE 2000 intact PTH assays of plasma and serum from dialysis patients. Clin Chem 2005;51:913-5.
Morales Garcia AI, Gorriz Teruel JL, Plancha Mansanet MC, Escudero Quesada V, Pallardo Mateu LM. Analysis of variability in determining intact parathyroid hormone (iPTH) according to the method used to process the sample. Nefrologia 2009;29:331-5.
Parent X, Alenabi F, Brignon P, Souberbielle J-C. Delayed measurement of PTH in patients with CKD: storage of the primary tube in the dialysis unit, which temperature Which kind of tube Nephrol Ther 2009;5:34-40.
Joly D, Drueke TB, Alberti C, Houillier P, Lawson-Body E, Martin KJ, et al. Variation in serum and plasma PTH levels in secondgeneration assays in hemodialysis patients: A cross-sectional study. Am J Kidney Dis. 2008;51:987-95.
Parent X, Alenabi F, Etienne E, Brignon P, Chantrel F, Meynaud-Kraemer L. Variabilite pre-analytique du dosage de la parathormone chez le patient dialyse; application a l'automate Elecsys 2010 (Roche). Ann Biol Clin (Paris) 2008;66:53-8.
Ratcliffe W, Heath D, Ryan M, Jones SR. Performance and diagnostic application of a two-site immunoradiometric assay for parathyrin in serum. Clin Chem 1989;35:1957-61.
Stokes FJ, Ivanov P, Bailey LM, Fraser WD. The effects of sampling procedures and storage conditions on short-term stability of blood-based biochemical markers of bone metabolism. Clin Chem 2011;57:138-40.
Cavalier E, Delanaye P, Hubert P, Krzesinski JM, Chapelle JP, Rozet E. Estimation of the stability of parathyroid hormone when stored at 80°C for a long period. Clin J Am Soc Nephrol 2009;4:1988-92.
Teal TK, Wood JL, Stevens PE, Lamb EJ. Stability of bio-intact (1-84) parathyroid hormone ex vivo in serum and EDTA plasma from hemodialysis patients. Clin Chem 2004;50:1713-4.
ISO Guide 30:2015. Terms and conditions used in connection with reference materials.
Cavalier E, Carlisi A, Bekaert A-C, Rousselle O, Chapelle JP, Delanaye P. New insights on the stability of the parathyroid hormone as assayed by an automated 3rd generation PTH assay. Clin Chim Acta 2012;413:353-4. Available at: http://dx. doi. org/10. 1016/j. cca. 2011. 09. 034. Accessed: 3 Oct 2011.
World Health Organization. Use of anticoagulants in diagnostic laboratory investigations. 2002.
ISO Guide 5725-6:1994. Accuracy (trueness and precision) of measurement methods and results-part 6: use in practice of accuracy values.
Gardham C, Stevens PE, Delaney MP, LeRoux M, Coleman A, Lamb EJ. Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis. Clin J Am Soc Nephrol 2010;5:1261-7.
Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409-37.
Forsberg G, Brobjer M, Holmgren E, Bergdahl K, Persson P, Gautvik KM, et al. Thrombin and H64A subtilisin cleavage of fusion proteins for preparation of human recombinant parathyroid hormone. J Protein Chem 1991;10:517-26.
La'ulu SL, Straseski JA, Schmidt RL, Genzen JR. Thrombin-mediated degradation of parathyroid hormone in serum tubes. Clin Chim Acta 2014;437:191-6. Available at: http://linkinghub. elsevier. com/retrieve/pii/S000989811400326X. Accessed: 30 Jul 2014.
Cavalier E, Delanaye P, Moranne O. Variability of new bone mineral metabolism markers in patients treated with maintenance hemodialysis: implications for clinical decision making. Am J Kidney Dis 2013;61:847-8. Available at: http://www. ncbi. nlm. nih. gov/pubmed/23357107. Accessed: 26 Jan 2013.
